Literature DB >> 18594

Solubility and ionization characteristics of phenytoin.

P A Schwartz, C T Rhodes, J W Cooper.   

Abstract

The solubility of phenytoin was determined in pH 7.4 and 5.4 phosphate buffers at five temperatures; in hydroalcoholic solutions, 0--4% methanol; and in pH 4.8--8.4 buffer solutions. From the temperature data, the enthalpy and entropy of solution of this nonideal system were calculated and were similar at both pH values. The data obtained from the buffer solutions were used to calculate the apparent dissociation constant, pKa', of phenytoin as 8.06. A GLC method with on-column methylation was used to quantitate phenytoin with 5-(p-methyl-phenyl)-5-phenylhydantoin as an internal standard. The assay uses chloroform of extraction of the drug from aqueous solutions. The ratio of peak heights was adjusted for weights of aqueous and organic layers, and results were calculated in micrograms per gram of sample and mole fraction of phenytoin. Although hydroalcoholic solutions enhanced drug solubility, there is a potentially significant disadvantage in using alcohol for clinical studies.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 18594     DOI: 10.1002/jps.2600660724

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Nutrient influences on rat intestinal phenytoin uptake.

Authors:  D Fleisher; N Sheth; H Griffin; M McFadden; G Aspacher
Journal:  Pharm Res       Date:  1989-04       Impact factor: 4.200

2.  Estimation of the increase in solubility of drugs as a function of bile salt concentration.

Authors:  S D Mithani; V Bakatselou; C N TenHoor; J B Dressman
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

3.  Phenytoin-lipid conjugates: chemical, plasma esterase-mediated, and pancreatic lipase-mediated hydrolysis in vitro.

Authors:  G K Scriba
Journal:  Pharm Res       Date:  1993-08       Impact factor: 4.200

4.  Development of a novel approach to enhance the solubility of ftibamzone formulation.

Authors:  Ofonime Udofot; Kristen Jaruszewski; Shawn Spencer; Edward Agyare
Journal:  Integr Mol Med       Date:  2014
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.